143 related articles for article (PubMed ID: 36417826)
1. Identification of an N-phenylsulfonyl-2-(piperazin-1-yl)methyl-benzonitrile derivative as Zika virus entry inhibitor.
Quan Y; Zhou R; Yang B; Wang L; Wang Y; Ji Y; Li Y; Cen S
Bioorg Chem; 2023 Jan; 130():106265. PubMed ID: 36417826
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum.
Ji Y; Wang L; Zhou R; Yang X; Li S; Cen S; Li Y
Bioorg Med Chem; 2024 Apr; 103():117682. PubMed ID: 38493729
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
4. Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.
Lai ZZ; Ho YJ; Lu JW
Molecules; 2020 Sep; 25(18):. PubMed ID: 32906689
[TBL] [Abstract][Full Text] [Related]
5. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel 2'-methyl-2'-fluoro-6-methyl-7-alkynyl-7-deazapurine nucleoside analogs as anti-Zika virus agents.
Yao G; Yu J; Lin C; Zhu Y; Duan A; Li M; Yuan J; Zhang J
Eur J Med Chem; 2022 Apr; 234():114275. PubMed ID: 35306290
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
8. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
9. Identification of Ascomycin against Zika virus infection through screening of natural product library.
Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
[TBL] [Abstract][Full Text] [Related]
10. Atranorin inhibits Zika virus infection in human glioblastoma cell line SNB-19 via targeting Zika virus envelope protein.
Huang GG; Wang HY; Wang XH; Yang T; Zhang XM; Feng CL; Zhao WM; Tang W
Phytomedicine; 2024 Mar; 125():155343. PubMed ID: 38290230
[TBL] [Abstract][Full Text] [Related]
11. Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection.
Lu JW; Chen YC; Huang CK; Lin KC; Ho YJ
Antiviral Res; 2021 Nov; 195():105188. PubMed ID: 34648875
[TBL] [Abstract][Full Text] [Related]
12. The calcium channel inhibitor lacidipine inhibits Zika virus replication in neural progenitor cells.
Bezemer B; van Cleef KWR; Overheul GJ; Miesen P; van Rij RP
Antiviral Res; 2022 Jun; 202():105313. PubMed ID: 35367280
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection.
Xu H; Cheng M; Chi X; Liu X; Zhou J; Lin T; Yang W
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270223
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of glycyrrhizic acid conjugates with amino acid esters against Zika virus.
Baltina LA; Hour MJ; Liu YC; Chang YS; Huang SH; Lai HC; Kondratenko RM; Petrova SF; Yunusov MS; Lin CW
Virus Res; 2021 Mar; 294():198290. PubMed ID: 33388394
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV.
Zhou GF; Li F; Xue JX; Qian W; Gu XR; Zheng CB; Li C; Yang LM; Xiong SD; Zhou GC; Zheng YT
Virus Res; 2023 Mar; 326():199062. PubMed ID: 36746341
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Zika Virus Inhibitors: A Screening using Thiosemicarbazones and Thiazoles Templates.
de Moraes Gomes PAT; Barros Freitas LA; Pessoa Siqueira LR; da Conceição JM; Dos Santos IR; Pinto AF; de Melo Silva VG; Nunes JS; de Oliveira Cardoso MV; Pena LJ; Lima Leite AC
Curr Top Med Chem; 2023; 23(6):426-439. PubMed ID: 36567284
[TBL] [Abstract][Full Text] [Related]
17. The in vitro and in vivo antiviral effects of aloperine against Zika virus infection.
Zhou P; Lao Z; Long H; Pan P; Liao F; Zheng W; Li Z; Dai J; Liu H; Jiang Y; Liu X; Wang W; Wu J; Li G
J Med Virol; 2023 Jul; 95(7):e28913. PubMed ID: 37409639
[TBL] [Abstract][Full Text] [Related]
18. Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options.
Koppolu V; Shantha Raju T
J Neurovirol; 2018 Jun; 24(3):255-272. PubMed ID: 29441490
[TBL] [Abstract][Full Text] [Related]
19. Anti-zika virus activity of polyoxometalates.
Francese R; Civra A; Rittà M; Donalisio M; Argenziano M; Cavalli R; Mougharbel AS; Kortz U; Lembo D
Antiviral Res; 2019 Mar; 163():29-33. PubMed ID: 30653996
[TBL] [Abstract][Full Text] [Related]
20. Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator.
Wang X; Xia S; Zou P; Lu L
Viruses; 2019 Nov; 11(11):. PubMed ID: 31731598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
